{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:22:36Z","timestamp":1769876556541,"version":"3.49.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/iop.0b013e3182805a2a","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T12:48:03Z","timestamp":1361969283000},"page":"196-197","source":"Crossref","is-referenced-by-count":11,"title":["Patient-Reported Benefit From Botulinum Toxin Treatment for Essential Blepharospasm"],"prefix":"10.1097","volume":"29","author":[{"given":"Richard M. H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haziq R.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N.","family":"Hyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole A.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","article-title":"Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm.","volume":"13","author":"Ochudlo","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00702-010-0546-9","article-title":"Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.","volume":"118","author":"Wabbels","year":"2011","journal-title":"J Neural Transm"},{"key":"R3-11-20210129","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/01676830490506041","article-title":"Impact on quality of life of botulinum toxin treatments for essential blepharospasm.","volume":"23","author":"MacAndie","year":"2004","journal-title":"Orbit"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/000348949610500601","article-title":"Measuring patient benefit from otorhinolaryngological surgery and therapy.","volume":"105","author":"Robinson","year":"1996","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.22368","article-title":"Relationship between various clinical outcome assessments in patients with blepharospasm.","volume":"24","author":"Jankovic","year":"2009","journal-title":"Mov Disord"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IOP.0b013e3182805a2a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:52:45Z","timestamp":1620957165000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002341-201305000-00011"}},"subtitle":["Using 2 Assessment Scales"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e3182805a2a","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}